Outcome of Arterio-venous Fistula for Adult Hemodialysis Patients in Assiut Governorate

Chronic Renal Failure Clinical Trial

Official title:

Outcome of Arterio-venous Fistula for Adult Hemodialysis Patients in Assiut Governorate

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03397381
• Other study ID #: 17200155
• Status: Recruiting
• Start date: January 20, 2018
• Est. completion date: January 1, 2022

Study information

• Verified date: January 2019
• Source: Assiut University
• Contact: Hanan S Mahrous, MD
• Phone: 0201017031500
• Email: mostafak198173[@]yahoo.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

identification of the factors that affect the outcome of arteriovenous fistula in chronic renal failure patients that newly established regular dialysis in Assiut Governorate

1. To study the factors that influence the outcome of AVF

2. To evaluate the vascular complications of AVF as occlusion, rupture, aneurysmal dilation and hand ischemia

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Est. completion date: January 1, 2022
• Est. primary completion date: January 1, 2021
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all adult hemodialysis Patients in Assiut Government are eligible for enrollment if they are newly dialyzed via AVF and agree to participate in the study

Exclusion Criteria:

• Patients are not dialyzed with AVF

Related Conditions & MeSH terms

• Arteriovenous Fistula
• Chronic Renal Failure
• Fistula
• Kidney Failure, Chronic
• Renal Insufficiency

Locations

Country	Name	City	State
Egypt	Hanan	Assiut

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (5)

Hammes M. Hemodynamic and biologic determinates of arteriovenous fistula outcomes in renal failure patients. Biomed Res Int. 2015;2015:171674. doi: 10.1155/2015/171674. Epub 2015 Oct 1. Review. — View Citation

Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007 Sep;2(5):1043-53. Epub 2007 Aug 16. Review. — View Citation

Padberg FT Jr, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: recognition and management. J Vasc Surg. 2008 Nov;48(5 Suppl):55S-80S. doi: 10.1016/j.jvs.2008.08.067. Review. — View Citation

Stolic R. Most important chronic complications of arteriovenous fistulas for hemodialysis. Med Princ Pract. 2013;22(3):220-8. doi: 10.1159/000343669. Epub 2012 Nov 2. Review. — View Citation

Valliant A, McComb K. Vascular Access Monitoring and Surveillance: An Update. Adv Chronic Kidney Dis. 2015 Nov;22(6):446-52. doi: 10.1053/j.ackd.2015.06.002. Review. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	the number of new renal failure patients with failed arteriovenous fistula as measured with arteriovenous duplex ultrasound imaging peak systolic velocity and end-diastolic velocity in Assiut Governorate	the arteriovenous fistula will be named fail if one or more of the following; No Doppler signal; Ratio of peak systolic velocity at stenosis to peak systolic velocity at 2 cm beyond anastomosis (if normal)appearing >3; Intraluminal echogenicity; Graft walls appear collapsed	3 years
Secondary	the number deaths of renal failure patients on regular dialysis related to AVF complications in Assiut Governorate		3 years